Viatris Inc.
VTRSDrug Manufacturers - Specialty & Generic
$19.04−0.86%As of Oct 30vs prior close
- Market cap
- $21.9B
- P/E (TTM)
- –
- P/E (FY1)
- 7.6×
- From 52W high
- −0.86%
- EPS (LTM)
- -$0.40
- Revenue (LTM)
- $14.7B
- Dividend yield
- 2.52%
Nomior Score
64
Steady ProfileTop 18% of the scored universe
Growth26
Quality47
Value72
Momentum98
Resilience53
Growth
+3.25%revenue a year over 7 fiscal years
YE18 $11.4BLTM $14.7B
Connections
Revenue to profitQ2 YE26
The net loss was 3% of revenue, wider by 3 pts on a year.
Who owns it
5funds, 3 tracked portfolios